Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of GlycoMimetics Inc (NASDAQ: GLYC) closed at $0.26 in the last session, up 3.09% from day before closing price of $0.25. In other words, the price has increased by $3.09 from its previous closing price. On the day, 0.22 million shares were traded. GLYC stock price reached its highest trading level at $0.275 during the session, while it also had its lowest trading level at $0.253.
Ratios:
We take a closer look at GLYC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.62 and its Current Ratio is at 3.62. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.00.
On December 22, 2023, CapitalOne started tracking the stock assigning a Overweight rating and target price of $12.
Jefferies Upgraded its Hold to Buy on November 12, 2021, whereas the target price for the stock was revised from $3 to $4.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 08 ’24 when Invus Public Equities, L.P. sold 260,873 shares for $0.19 per share. The transaction valued at 50,009 led to the insider holds 6,317,565 shares of the business.
Invus Public Equities, L.P. sold 61,488 shares of GLYC for $11,197 on Aug 07 ’24. The 10% Owner now owns 6,578,438 shares after completing the transaction at $0.18 per share. On Aug 05 ’24, another insider, Invus Public Equities, L.P., who serves as the 10% Owner of the company, sold 164,523 shares for $0.19 each. As a result, the insider received 30,996 and left with 6,695,658 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GLYC now has a Market Capitalization of 16778580 and an Enterprise Value of 3817615. For the stock, the TTM Price-to-Sale (P/S) ratio is 1677.00 while its Price-to-Book (P/B) ratio in mrq is 1.47. Its current Enterprise Value per Revenue stands at 381.762 whereas that against EBITDA is -0.094.
Stock Price History:
The Beta on a monthly basis for GLYC is 1.82, which has changed by -0.9166667 over the last 52 weeks, in comparison to a change of 0.23631513 over the same period for the S&P500. Over the past 52 weeks, GLYC has reached a high of $3.53, while it has fallen to a 52-week low of $0.14. The 50-Day Moving Average of the stock is -13.52%, while the 200-Day Moving Average is calculated to be -44.24%.
Shares Statistics:
According to the various share statistics, GLYC traded on average about 20.24M shares per day over the past 3-months and 316120 shares per day over the past 10 days. A total of 64.48M shares are outstanding, with a floating share count of 57.07M. Insiders hold about 11.50% of the company’s shares, while institutions hold 42.04% stake in the company. Shares short for GLYC as of 1730332800 were 5638593 with a Short Ratio of 0.11, compared to 1727654400 on 1637061. Therefore, it implies a Short% of Shares Outstanding of 5638593 and a Short% of Float of 12.61.
